光フェレシス製品市場：製品、治療領域、エンドユーザー別-2025-2030年の世界予測

光フェレシス製品市場は、2023年に5億1,434万米ドルと評価され、2024年には5億5,219万米ドルに達すると予測され、CAGR 7.83%で成長し、2030年には8億7,237万米ドルに達すると予測されています。

光フェレシスとは、紫外線と光増感剤による血液の体外処理を含む治療法で、主に皮膚T細胞リンパ腫、移植片対宿主病、一部の自己免疫疾患などの治療に使用されます。光フェレーシス製品の世界市場は、これらの免疫関連疾患の有病率の増加、医療技術の進歩、個別化医療の重視の高まりによって牽引されています。その必要性は、従来の治療法に比べて副作用の少ない代替治療の必要性に起因しています。その用途は病院、専門クリニック、外来手術センターなど多岐にわたり、病気の治療や再発予防の役割を果たすこともあります。エンドユーザーには、主に腫瘍学や血液学を専門とするヘルスケアプロバイダーが含まれます。市場に影響を与える主な発展要因としては、患者数の増加、医療支出の増加、医療インフラが急速に発展している新興国市場への注力の強化などが挙げられます。光フェレーシス装置へのAIの統合のような技術革新は、注目すべき機会を提供しています。しかし、装置のコストが高いこと、規制要件が厳しいこと、治療の利点に関する認識が広まっていないことなどにより、市場の成長は制限されています。さらに、このような高度な装置の操作や管理には熟練した専門家が必要であり、未発達地域ではこれが制限要因となりうる。革新的な調査は、光フェレーシス装置の有効性と手頃な価格を改善し、新たな臨床適応の可能性を探ることを目標としています。製薬企業や学術機関との戦略的な共同研究は、製品開発を加速させる可能性があります。さらに、光フェレーシスに関するアウトリーチや教育を強化することで、より大きな市場シェアを獲得できる可能性があります。市場競争は激しく、絶え間ない技術革新が特徴であり、治療効果と患者の転帰を向上させるデジタルヘルスソリューションの統合が進む傾向にあります。

市場力学：急速に進化する光フェレシス製品市場の主要市場インサイトを公開

光フェレシス製品市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 自己免疫疾患およびがん疾患の有病率の上昇
  • 世界のヘルスケア支出の増加と慢性疾患に対する意識の高まり
• 市場抑制要因
  • 光フェレシス治療に伴う高コスト
• 市場機会
  • 光フェレーシス製品の技術的進歩
  • 光フェレシス製品メーカーとヘルスケア機関の合併活動
• 市場の課題
  • 光フェレシス製品と治療に関連する規制と償還の問題

ポーターのファイブフォース：光フェレシス製品市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：光フェレシス製品市場における外部からの影響の把握

外部マクロ環境要因は、光フェレシス製品市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析光フェレシス製品市場における競合情勢の把握

光フェレシス製品市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス光フェレシス製品市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、光フェレシス製品市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨光フェレシス製品市場における成功への道筋を描く

光フェレシス製品市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 自己免疫疾患およびがんの罹患率の上昇
    • 世界のヘルスケア費の増加と慢性疾患に対する意識の高まり
  • 抑制要因
    • フォトフェレーシス治療に伴う高額な費用
  • 機会
    • フォトフェレシス製品の技術的進歩
    • 光フェレシス製品メーカーとヘルスケア機関の合併活動
  • 課題
    • フォトフェレシス製品および治療に関連する規制および償還の問題
• 市場セグメンテーション分析
  • 製品：患者の安全性向上のため、クローズドシステムの採用が増加
  • エンドユーザー：総合的な治療環境を提供する病院におけるフォトフェレシス製品のニーズが高まっている
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 光フェレシス製品市場：製品別

• クローズドシステム
• オープンシステム

第7章 光フェレシス製品市場治療領域別

• 自己免疫疾患
• 皮膚T細胞リンパ腫
• 移植片対宿主病
• 固形臓器移植の拒絶反応

第8章 光フェレシス製品市場：エンドユーザー別

• 外来センター
• 病院
• 専門クリニック

第9章 南北アメリカの光フェレシス製品市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の光フェレシス製品市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの光フェレシス製品市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • フレゼニウスカビ、アミカスセパレーターにシングルニードル機能を導入
  • 日本、慢性GVHD治療におけるマリンクロット社のCELLEXフォトフェレーシスシステムの保険償還を承認
• 戦略分析と提言

企業一覧

• BioCardia, Inc.
• Bristol-Myers Squibb Company
• Fresenius SE & Co. KGaA
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.
• Macopharma
• Mallinckrodt Pharmaceuticals
• Merck & Co., Inc.
• Pfizer Inc.
• PIT Medical Systems GmbH
• Sanofi S.A.
• Terumo Corporation
• Transimmune AG

LIST OF FIGURES

• FIGURE 1. PHOTOPHERESIS PRODUCT MARKET RESEARCH PROCESS
• FIGURE 2. PHOTOPHERESIS PRODUCT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PHOTOPHERESIS PRODUCT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PHOTOPHERESIS PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PHOTOPHERESIS PRODUCT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PHOTOPHERESIS PRODUCT MARKET DYNAMICS
• TABLE 7. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY CUTANEOUS T-CELL LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY GRAFT VERSUS HOST DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY SOLID ORGAN TRANSPLANT REJECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. CANADA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. CANADA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 31. CANADA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. CHINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. CHINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 48. CHINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. INDIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. INDIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 51. INDIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. ITALY PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. ITALY PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 103. ITALY PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. POLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. POLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 115. POLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. QATAR PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. QATAR PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 118. QATAR PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. PHOTOPHERESIS PRODUCT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. PHOTOPHERESIS PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023

The Photopheresis Product Market was valued at USD 514.34 million in 2023, expected to reach USD 552.19 million in 2024, and is projected to grow at a CAGR of 7.83%, to USD 872.37 million by 2030.

Photopheresis, a therapeutic procedure involving the extracorporeal treatment of blood with UV light and photosensitizing agents, is primarily used to treat conditions like cutaneous T-cell lymphoma, graft versus host disease, and some autoimmune disorders. The global market for photopheresis products is driven by the increasing prevalence of these immune-related disorders, advancements in medical technologies, and a growing emphasis on personalized medicine. Its necessity stems from the need for alternative treatments that offer fewer side effects compared to conventional therapies. The applications span across hospitals, specialty clinics, and ambulatory surgical centers, where it serves as a therapeutic and sometimes preventative measure against disease relapse. End-users mainly include healthcare providers specializing in oncology and hematology. Key growth factors influencing the market include a rising patient pool, increased healthcare spending, and stronger focus on emerging markets where healthcare infrastructure is rapidly developing. Technological innovations, like the integration of AI in photopheresis machines, present notable opportunities. However, market growth is limited by the high cost of devices, stringent regulatory requirements, and a lack of widespread awareness regarding the treatment's benefits. Moreover, skilled professionals are required to operate and manage these sophisticated devices, which can be a limiting factor in underdeveloped regions. Innovative research could target improving the efficacy and affordability of photopheresis equipment and exploring potential new clinical indications. Strategic collaborations with pharmaceutical firms and academic institutions could accelerate product development. Furthermore, increasing outreach and education about photopheresis could help in capturing a larger market share. The market is highly competitive and characterized by continuous innovation, with trends pointing towards a greater integration of digital health solutions to enhance treatment efficacy and patient outcomes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Photopheresis Product Market

The Photopheresis Product Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of autoimmune and cancer diseases
  • Increased global healthcare spending and growing awareness about chronic diseases
• Market Restraints
  • High costs associated with photopheresis treatments
• Market Opportunities
  • Technological advancements in photopheresis products
  • Amalgamation activities between photopheresis product manufacturers and healthcare institutions
• Market Challenges
  • Regulatory and reimbursement issues associated with photopheresis products and treatments

Porter's Five Forces: A Strategic Tool for Navigating the Photopheresis Product Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Photopheresis Product Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Photopheresis Product Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Photopheresis Product Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Photopheresis Product Market

A detailed market share analysis in the Photopheresis Product Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Photopheresis Product Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Photopheresis Product Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Photopheresis Product Market

A strategic analysis of the Photopheresis Product Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Photopheresis Product Market, highlighting leading vendors and their innovative profiles. These include BioCardia, Inc., Bristol-Myers Squibb Company, Fresenius SE & Co. KGaA, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Macopharma, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Pfizer Inc., PIT Medical Systems GmbH, Sanofi S.A., Terumo Corporation, and Transimmune AG.

Market Segmentation & Coverage

This research report categorizes the Photopheresis Product Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Closed System and Open System.
• Based on Therapeutic Area, market is studied across Autoimmune Diseases, Cutaneous T-cell Lymphoma, Graft Versus Host Diseases, and Solid Organ Transplant Rejections.
• Based on End User, market is studied across Ambulatory Centers, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of autoimmune and cancer diseases
    • 5.1.1.2. Increased global healthcare spending and growing awareness about chronic diseases
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with photopheresis treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in photopheresis products
    • 5.1.3.2. Amalgamation activities between photopheresis product manufacturers and healthcare institutions
  • 5.1.4. Challenges
    • 5.1.4.1. Regulatory and reimbursement issues associated with photopheresis products and treatments
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing adoption of closed systems for increased patient safety
  • 5.2.2. End User: Higher need for photopheresis products in hospitals to offer a comprehensive treatment environment
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Photopheresis Product Market, by Product

• 6.1. Introduction
• 6.2. Closed System
• 6.3. Open System

7. Photopheresis Product Market, by Therapeutic Area

• 7.1. Introduction
• 7.2. Autoimmune Diseases
• 7.3. Cutaneous T-cell Lymphoma
• 7.4. Graft Versus Host Diseases
• 7.5. Solid Organ Transplant Rejections

8. Photopheresis Product Market, by End User

• 8.1. Introduction
• 8.2. Ambulatory Centers
• 8.3. Hospitals
• 8.4. Specialty Clinics

9. Americas Photopheresis Product Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Photopheresis Product Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Photopheresis Product Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Fresenius Kabi Introduces Single-Needle Function in Amicus Separator
  • 12.3.2. Japan Approves Reimbursement for Mallinckrodt's CELLEX Photopheresis System in Treating Chronic GVHD
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. BioCardia, Inc.
• 2. Bristol-Myers Squibb Company
• 3. Fresenius SE & Co. KGaA
• 4. Johnson & Johnson Services, Inc.
• 5. Koninklijke Philips N.V.
• 6. Macopharma
• 7. Mallinckrodt Pharmaceuticals
• 8. Merck & Co., Inc.
• 9. Pfizer Inc.
• 10. PIT Medical Systems GmbH
• 11. Sanofi S.A.
• 12. Terumo Corporation
• 13. Transimmune AG